Director, Government Affairs & Policy at Bristol-Myers Squibb

Kariya-shi, Aichi, Japan

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Bachelor’s degree or higher
  • At least 7-10 years of experience in government affairs, public policy, or related fields
  • Deep understanding of Japan Health Policy system, pricing & access policies, decision-making processes and legislative procedures
  • Demonstrated ability to significantly influence critical policy and/or business issues
  • Ability to prioritize and manage workloads, leverage resources efficiently and respond and adapt quickly in a challenging and fast-paced environment
  • Excellent relationship-building skills with a superior ability to articulate ideas to various audiences
  • Ability to work collaboratively with cross-functional teams and stakeholders
  • Proven ability to communicate business critical information at senior levels in the global and in Japan, and to reconcile multiple stakeholder views
  • Excellent communication and presentation skills (English and Japanese)
  • Fluent in English

Responsibilities

  • Develop and execute the company's integrated government affairs & market access policy strategy in close partnership with cross-functional partners
  • Build and enact targeted environment shaping activities to create a positive and favorable landscape for BMSKK products and protect the business of the Japanese affiliate from potential threats and risks
  • Engage with diet members, trade association partners, policy stakeholders, key opinion leaders, and other influencers to promote a positive presence for BMSKK and educate and communicate BMSKK policy priorities
  • Identify strategic opportunities to develop external policy relationships that will further the policy interests and positions of BMSKK
  • Create and oversee the government affairs budget
  • Partner with internal and external stakeholders to develop actionable pricing & reimbursement policy frameworks and drive their legislative implementation
  • Evaluate current and emerging policy trends and developments and advise senior company leadership on risk management and business strategies
  • Participate, serve, and assume leadership positions in industry associations (PhRMA, JPMA, FIRM), steering committees, and networking organizations to protect & promote BMS interest

Skills

Government Affairs
Market Access
Policy Strategy
Advocacy
Stakeholder Engagement
Project Management
Regulatory Knowledge
Communication

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI